Do you want to read an article? Please log in or register.
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy
Retinal Diseases
Related content
Macular DiseasesRetinal Diseases
Long-term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes with Diabetic Macular Edema treated with Anti-VEGF Therapy
Am J Ophthalmol
Borrelli E, Grosso D, Barresi C, Lari G, Sacconi R, Senni C, Querques L, Bandello F, Querques G
doi: 10.1016/j.ajo.2021.09.002
Retinal Diseases
Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
Front Pharmacol
Fasler K, Gunzinger JM, Barthelmes D, Zweifel SA
doi: 10.3389/fphar.2021.675295
Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy
JAMA Ophthalmol.
van Dijk EH, Schellevis RL, van Bergen MG, Breukink MB, Altay L, Scholz P, Fauser S, Meijer OC, Hoyng CB, den Hollander AI, Boon CJ, de Jong EK
doi: 10.1001/
Retinal Diseases
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial
Ophthalmology.
van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF
doi: 10.1016/j.ophtha.
Retinal DiseasesUveitis
Predictors of Long-Term Visual Outcome in Intermediate Uveitis.
Ophthalmology.
Niederer RL, Sharief L, Bar A, Lightman SL, Tomkins-Netzer O
doi: 10.1016/
COMMENTED
Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study
JAMA Ophthalmol.
Schellevis RL, van Dijk EHC, Breukink MB, Altay L, Bakker B, Koeleman BPC, Kiemeney LA, Swinkels DW, Keunen JEE, Fauser S, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK
doi: 10.1001/jamaophthalmol.
COMMENTED
Retinal Diseases
Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience
Br J Ophthalmol.
Petkovsek DS, Cherfan DG, Conti FF, Hom GL, Ehlers JP, Babiuch AS, Rachitskaya AV, Kaiser PK, Schachat AP, Srivastava SK, Sharma S, Singh RP
doi: 10.1136/bjophthalmol-2019-314047.
COMMENTED
Retinal Diseases
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
★ 2
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
★ 3
Recommended by
Dr Katarzyna Konieczka, Faculty Member
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Lancet.
Lotery A, Sivaprasad S, O'Connell A, Harris RA, Culliford L, Ellis L, Cree A, Madhusudhan S, Behar-Cohen F, Chakravarthy U, Peto T, Rogers CA, Reeves BC, VICI trial investigators
doi: 10.1016/S0140-6736(19)32981-2.
Macular Diseases
Projection of long-term visual acuity outcomes based on initial treatment response in neovascular age-related macular degeneration
Ophthalmology.
Nguyen V, Daien V, Guymer R, Young S, Hunyor A, Fraser-Bell S, Hunt A, Gillies MC, Barthelmes D; Fight Retinal Blindness! Study Group
doi: 10.1016/j.ophtha.